These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36789997)

  • 1. Cardiac amyloidosis: a significant blind spot of the H2FPEF score.
    Duca F; Rettl R; Binder C; Dusik F; Schrutka L; Dalos D; Öztürk B; Capelle CD; Qin H; Dachs TM; Camuz Ligios L; Agis H; Kain R; Hengstenberg C; Badr-Eslam R; Kastner J; Bonderman D
    Panminerva Med; 2023 Dec; 65(4):491-498. PubMed ID: 36789997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the HFA-PEFF and H
    Tomasoni D; Aimo A; Merlo M; Nardi M; Adamo M; Bellicini MG; Cani D; Franzini M; Khalil A; Pancaldi E; Panichella G; Porcari A; Rossi M; Vergaro G; Lombardi CM; Sinagra G; Rapezzi C; Emdin M; Metra M
    Eur J Heart Fail; 2022 Dec; 24(12):2374-2386. PubMed ID: 35855616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An echo score raises the suspicion of cardiac amyloidosis in Chinese with heart failure with preserved ejection fraction.
    Yang H; Li R; Ma F; Wei Y; Liu Y; Sun Y; He X; Zeng H; Yan J; Wang DW; Wang H
    ESC Heart Fail; 2022 Dec; 9(6):4280-4290. PubMed ID: 36128643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
    Davies DR; Redfield MM; Scott CG; Minamisawa M; Grogan M; Dispenzieri A; Chareonthaitawee P; Shah AM; Shah SJ; Wehbe RM; Solomon SD; Reddy YNV; Borlaug BA; AbouEzzeddine OF
    JAMA Cardiol; 2022 Oct; 7(10):1036-1044. PubMed ID: 36069809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility and Validity of the HFA-PEFF and H
    Ariyaratnam JP; Mishima RS; Kadhim K; Emami M; Fitzgerald JL; Thiyagarajah A; Dziano JK; Howie JO; Middeldorp ME; Sanders P; Elliott AD
    JACC Heart Fail; 2024 Jun; 12(6):1015-1025. PubMed ID: 38520461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.
    Hahn VS; Yanek LR; Vaishnav J; Ying W; Vaidya D; Lee YZJ; Riley SJ; Subramanya V; Brown EE; Hopkins CD; Ononogbu S; Perzel Mandell K; Halushka MK; Steenbergen C; Rosenberg AZ; Tedford RJ; Judge DP; Shah SJ; Russell SD; Kass DA; Sharma K
    JACC Heart Fail; 2020 Sep; 8(9):712-724. PubMed ID: 32653448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying the ESC 2016, H
    Nikorowitsch J; Bei der Kellen R; Kirchhof P; Magnussen C; Jagodzinski A; Schnabel RB; Blankenberg S; Wenzel JP
    ESC Heart Fail; 2021 Oct; 8(5):3603-3612. PubMed ID: 34459154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of SVI/S' and diagnostic scores for heart failure with preserved ejection fraction.
    Mu G; Wang W; Liu C; Xie J; Zhang H; Zhang X; Che J; Tse G; Liu T; Li G; Fu H; Chen K
    Clin Exp Pharmacol Physiol; 2023 Aug; 50(8):677-687. PubMed ID: 37203426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H
    Suzuki S; Kaikita K; Yamamoto E; Sueta D; Yamamoto M; Ishii M; Ito M; Fujisue K; Kanazawa H; Araki S; Arima Y; Takashio S; Usuku H; Nakamura T; Sakamoto K; Izumiya Y; Soejima H; Kawano H; Jinnouchi H; Matsui K; Tsujita K
    ESC Heart Fail; 2020 Feb; 7(1):65-74. PubMed ID: 31967406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of H
    Sun Y; Wang N; Li X; Zhang Y; Yang J; Tse G; Liu Y
    ESC Heart Fail; 2021 Apr; 8(2):1244-1252. PubMed ID: 33403825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
    Smiley DA; Rodriguez CM; Maurer MS
    Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.
    Ferkh A; Geenty P; Stefani L; Emerson P; Pham J; Byth K; Boyd AC; Richards D; Taylor MS; Kwok F; Kizana E; Thomas L
    ESC Heart Fail; 2024 Aug; ():. PubMed ID: 39129371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
    Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
    JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2FPEF Score Reflects the Left Atrial Strain and Predicts Prognosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Hwang IC; Cho GY; Choi HM; Yoon YE; Park JJ; Park JB; Park JH; Lee SP; Kim HK; Kim YJ
    J Card Fail; 2021 Feb; 27(2):198-207. PubMed ID: 33035685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
    Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
    Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems.
    Parcha V; Malla G; Kalra R; Patel N; Sanders-van Wijk S; Pandey A; Shah SJ; Arora G; Arora P
    ESC Heart Fail; 2021 Jun; 8(3):2089-2102. PubMed ID: 33709628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the H
    Ludwig S; Pellegrini C; Gossling A; Rheude T; Voigtländer L; Bhadra OD; Linder M; Kalbacher D; Koell B; Waldschmidt L; Schirmer J; Seiffert M; Reichenspurner H; Blankenberg S; Westermann D; Conradi L; Joner M; Schofer N
    ESC Heart Fail; 2021 Feb; 8(1):461-470. PubMed ID: 33215870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; Davies DR; Scott CG; Fayyaz AU; Askew JW; McKie PM; Noseworthy PA; Johnson GB; Dunlay SM; Borlaug BA; Chareonthaitawee P; Roger VL; Dispenzieri A; Grogan M; Redfield MM
    JAMA Cardiol; 2021 Nov; 6(11):1267-1274. PubMed ID: 34431962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
    Itzhaki Ben Zadok O; Vaturi M; Vaxman I; Iakobishvili Z; Rhurman-Shahar N; Kornowski R; Hamdan A
    PLoS One; 2021; 16(8):e0255487. PubMed ID: 34370783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.